You have 8 free searches left this month | for more free features.

Hypersomnia

Showing 26 - 50 of 465

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hypersomnia, Narcolepsy, Traumatic Brain Injury Trial in Boston (Sodium Oxybate Oral Solution [Xyrem])

Withdrawn
  • Hypersomnia
  • +2 more
  • Sodium Oxybate Oral Solution [Xyrem]
  • Boston, Massachusetts
    Brigham and Women's Hospital
Mar 2, 2021

Obstructive Sleep Apnea (OSA), Insomnia, Restless Leg Syndrome (RLS) Trial in Fontana (Sleep VS)

Active, not recruiting
  • Obstructive Sleep Apnea (OSA)
  • +4 more
  • Sleep VS
  • Fontana, California
    Sleep Center; Fontana Medical Center, Kaiser Permanente
Jul 5, 2022

Narcolepsy 1, Idiopathic Hypersomnia Trial in Zürich (Sleep restriction, Sleep deprivation)

Completed
  • Narcolepsy 1
  • Idiopathic Hypersomnia
  • Sleep restriction
  • Sleep deprivation
  • Zürich, Switzerland
    University Hospital Zurich
Feb 19, 2021

Idiopathic Hypersomnia Trial in Japan, United States (TAK-925, TAK-925 Placebo)

Completed
  • Idiopathic Hypersomnia
  • Alabaster, Alabama
  • +21 more
Mar 4, 2021

Idiopathic Hypersomnia Trial in Worldwide (JZP-258, Placebo Oral Solution)

Completed
  • Idiopathic Hypersomnia
  • Birmingham, Alabama
  • +62 more
Nov 18, 2021

Narcolepsy, Idiopathic Hypersomnia Trial in Chicago (Cognitive-Behavior Therapy for Hypersomnia (CBT-H))

Completed
  • Narcolepsy
  • Idiopathic Hypersomnia
  • Cognitive-Behavior Therapy for Hypersomnia (CBT-H)
  • Chicago, Illinois
    Center for Circadian and Sleep Medicine, Northwestern University
Nov 19, 2019

Dementia, Alzheimer, Circadian Rhythm Disorders Trial in Philadelphia (Tailored music listening intervention)

Completed
  • Dementia
  • +13 more
  • Tailored music listening intervention
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jan 12, 2021

Idiopathic Hypersomnia Trial in United States (Pentetrazol (PTZ), Placebo oral capsule)

Unknown status
  • Idiopathic Hypersomnia
  • Pentetrazol (PTZ)
  • Placebo oral capsule
  • Birmingham, Alabama
  • +31 more
Apr 28, 2020

Rare Disorders, Undiagnosed Disorders, Disorders of Unknown Prevalence Trial in Sioux Falls, Sydney

Recruiting
  • Rare Disorders
  • +309 more
    • Sioux Falls, South Dakota
    • +1 more
    Jun 20, 2022

    'A Profile of Physical Performance Variables inOut-patient Adult

    Suspended
    • Narcolepsy
    • +6 more
    • Assessment of physical performance variables
    • Dublin, Ireland
      Department of Physiotherapy, School of Medicine, Trinity College
    Jun 4, 2020

    Hypersomnia in Major Depressive Disorder

    Unknown status
    • Major Depressive Disorder
    • No intervention involved
    • Hong Kong, Hong Kong
      Department of psychiatry, Faculty of Medicine, The Chinese Unive
    Sep 3, 2019

    Sleep Apnea, Obstructive, OSA, Sleep Trial (Telemedicine & Humidification)

    Unknown status
    • Sleep Apnea, Obstructive
    • +4 more
    • Telemedicine & Humidification
    • (no location specified)
    Mar 6, 2020

    Improving the Assessment of Hypersomnolence

    Completed
    • Disorders of Excessive Somnolence
    • Pupillometry
    • +3 more
    • Madison, Wisconsin
      University of Wisconsin-Madison, Department of Psychiatry
    Aug 20, 2019

    Sleep in Psychiatric Inpatients

    Unknown status
    • Sleep Disturbance
    • +4 more
      • Zurich, Switzerland
        Psychiatric University Hospital Zurich
      Dec 12, 2019

      Obstructive Sleep Apnea Syndrome With Residual Excessive Daytime

      Recruiting
      • Sleep Apnea Syndromes
      • Treatment
      • Oggebbio, Italy
        Istituto Auxologico Italiano
      Mar 21, 2023

      Somnolence Disorder, Excessive Trial in Montpellier (scale of severity, blood sample)

      Recruiting
      • Somnolence Disorder, Excessive
      • scale of severity
      • blood sample
      • Montpellier, France
        UH Montpellier
      Nov 27, 2020

      Depression, MDD, Dysthymic Disorder Trial in Indianapolis (behavioral, drug, other)

      Recruiting
      • Depression
      • +6 more
      • Good Days Ahead (GDA)
      • +3 more
      • Indianapolis, Indiana
        IUPUI Department of Psychology
      Jan 18, 2022

      Neurophysiologic Correlates of Hypersomnia

      Completed
      • Major Depressive Disorder
      • +4 more
      • Acoustical slow wave induction
      • Madison, Wisconsin
        University of Wisconsin-Madison, Department of Psychiatry
      Dec 21, 2018

      Current Major Depressive Episode (SAMDE)

      Recruiting
      • Depressive Episode
      • +4 more
      • MEB-001
      • Blaine, Minnesota
        Lakeland Sleep Store
      Jan 23, 2023

      Healthy, Premenstrual Dysphoric Disorder, Premenstrual Syndrome Trial in Glendale (Mixhers HERTIME, Placebo)

      Active, not recruiting
      • Healthy
      • +2 more
      • Mixhers HERTIME
      • Placebo
      • Glendale, Arizona
        Midwestern University
      Nov 15, 2023

      Depressive Disorder, Major, Inflammation Trial in Amsterdam (Celecoxib 400mg, Placebo)

      Recruiting
      • Depressive Disorder, Major
      • Inflammation
      • Celecoxib 400mg
      • Placebo
      • Amsterdam, Netherlands
        Department of Psychiatry Amsterdam UMC
      Sep 28, 2022

      Gut Microbiota and Bacterial Translocation in Restless Legs

      Not yet recruiting
      • Restless Legs Syndrome
      • Fecal collection
      • +3 more
      • Montpellier, France
        Unité des troubles du sommeil et de l'éveil-Centre de référence
      Aug 9, 2023

      PTSD, Insomnia, Nightmare Trial in Kansas City (Written Exposure Therapy (WET), Cognitive Behavioral Therapy for Insomnia

      Not yet recruiting
      • Posttraumatic Stress Disorder
      • +2 more
      • Written Exposure Therapy (WET)
      • +3 more
      • Kansas City, Missouri
        NDRI_USA
      Jul 14, 2023

      Multiple Sclerosis Trial in Montpellier (Magnetic Resonance Imaging, Blood withdrawal, Neuropsychological tests)

      Not yet recruiting
      • Multiple Sclerosis
      • Magnetic Resonance Imaging
      • +2 more
      • Montpellier, France
        Neurology Department, Hopital Gui de Chauliac
      Jul 18, 2023

      Myotonic Dystrophy, Type 1 (DM1), Myotonic Dystrophy Trial in United States (ERX-963, Placebo)

      Completed
      • Myotonic Dystrophy, Type 1 (DM1)
      • Myotonic Dystrophy
      • Palo Alto, California
      • +3 more
      Jun 22, 2021